Top Movers of the Day
Thursday, Jan 11, 2024 5:48 pm ET
Praxis Precision Medicines, Inc.'s (PRAX) stock price increased as the company announced the pricing of its $150 million public offering at $35.50 per share. Additionally, positive preliminary results were reported from PRAX-628 study in treating epilepsy patients, with full results expected in Q1 2024.